Adrian Clarke is a Scientific Advisor in Analytics at Novartis Pharma (Basel, Switzerland). His main responsibilities are: driving scientific excellence, identifying strategic and operational and technological needs; Defining, developing and implementing innovative state of the art analytics and regulatory control strategies.

He has more than 25 years’ experience working in the Pharma industry and in the last 5-10 years he has been actively involved in new modality and oligonucleotide projects.
His special interests are liquid phase separations & hyphenated techniques (Fast LC/UHPLC, 2D LC, SFC, MS), column characterisation, method development, and also analytical control & regulatory strategies, including new modalities, oligonucleotides and mutagenic impurities.

Adrian has DPhil in Analytical Chemistry (Separation sciences) from the University of York, UK. He has authored multiple publications and book chapters, he is a committee member of the Chromatographic Society, UK, and been on the organising committee of several international conferences (ISC2024, PBA2024, HPLC2025) and more than 10 ChromSoc UK scientific meetings, and he is also on the editor advisory board of LC-GC International.